5 Stocks Making Big Moves on Quarterly Results

2. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders: 88

Shares of Johnson & Johnson (NYSE:JNJ) closed higher on Tuesday, January 25, 2022, following its mixed financial performance for the fourth quarter.  The consumer goods and pharmaceutical company reported adjusted earnings of $2.13 per share, marginally beating the consensus forecast of $2.12 per share.

In addition, Johnson & Johnson (NYSE:JNJ) posted revenue of $24.804 billion, missing the expectations of $25.284 billion. If we look at the performance of its key business segments, consumer health revenue inched up 1.1 percent to $2.657 billion, pharma revenue jumped 16.5 percent to $14.288 billion, and medical devices revenue increased 4.1 percent to $6.859 billion in the quarter.

Looking forward, Johnson & Johnson (NYSE:JNJ) is expecting adjusted earnings in the range of $10.40 – $10.60 per share for 2022, above analysts’ average estimate of $10.35 per share.

Discussing the results, CEO of Johnson & Johnson (NYSE:JNJ), Joaquin Duato, said:

“Our 2021 performance reflects continued strength across all segments of our business. Guided by Our Credo, I am honored to assume the role of CEO, leading our global teams in continuing our work to deliver life-changing solutions to consumers, patients, and health care providers.”